First-line treatments in EGFR-mutated advanced non-small cell lung cancer: A network meta-analysis

摘要

Background It remains unknown which is the optimal first-line treatment regimen for patients with advanced epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). We performed a network meta-analysis to address this important issue.